Disc Medicine Correlations
| IRON Stock | 27.30 0.30 1.11% |
The correlation of Disc Medicine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Disc Medicine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Disc Medicine moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Average diversification
The correlation between Disc Medicine and NYA is 0.19 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Disc Medicine and NYA in the same portfolio, assuming nothing else is changed.
Disc |
The ability to find closely correlated positions to Disc Medicine could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Disc Medicine when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Disc Medicine - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Disc Medicine to buy it.
Moving together with Disc Stock
| 0.81 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
| 0.66 | GILD | Gilead Sciences Earnings Call Tomorrow | PairCorr |
Moving against Disc Stock
| 0.91 | ACB | Aurora Cannabis Trending | PairCorr |
| 0.83 | CGC | Canopy Growth Corp Trending | PairCorr |
| 0.72 | XFOR | X4 Pharmaceuticals Earnings Call Next Week | PairCorr |
| 0.66 | NRSNW | NeuroSense Therapeutics | PairCorr |
| 0.65 | ELYM | Eliem Therapeutics | PairCorr |
| 0.49 | ELEV | Elevation Oncology Earnings Call Next Week | PairCorr |
| 0.85 | ACRV | Acrivon Therapeutics Financial Report 14th of May 2024 | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Disc Stock performing well and Disc Medicine Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Disc Medicine's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ANEB | 2.62 | 0.28 | 0.04 | (0.51) | 3.50 | 6.20 | 20.75 | |||
| ADAG | 4.60 | 0.20 | 0.02 | (0.65) | 5.13 | 10.16 | 32.26 | |||
| ACRV | 6.42 | 1.58 | 0.26 | 1.28 | 4.91 | 17.65 | 73.69 | |||
| ANAB | 2.63 | (0.40) | 0.00 | (0.13) | 0.00 | 5.89 | 22.98 | |||
| MLYS | 2.93 | 0.26 | 0.12 | 0.19 | 3.12 | 6.29 | 26.82 | |||
| OLMA | 3.23 | (0.35) | 0.00 | (0.03) | 0.00 | 6.61 | 26.96 | |||
| LRMR | 4.77 | 0.57 | 0.16 | 0.26 | 4.38 | 11.62 | 52.23 | |||
| FENC | 1.75 | (0.21) | 0.00 | (0.08) | 0.00 | 2.96 | 16.83 | |||
| OBIO | 3.35 | (1.10) | 0.00 | (0.39) | 0.00 | 6.15 | 19.79 | |||
| BMEA | 4.11 | (0.48) | 0.00 | (0.07) | 0.00 | 9.40 | 30.14 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Disc Medicine without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run AI Investment Finder Now
AI Investment FinderUse AI to screen and filter profitable investment opportunities |
| All Next | Launch Module |
Disc Medicine Corporate Management
Elected by the shareholders, the Disc Medicine's board of directors comprises two types of representatives: Disc Medicine inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Disc. The board's role is to monitor Disc Medicine's management team and ensure that shareholders' interests are well served. Disc Medicine's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Disc Medicine's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Srikanth Venkatraman | Senior Chemistry | Profile | |
| Jonathan MBA | Chief Officer | Profile | |
| Jonathan Yu | Chief Officer | Profile | |
| Joanne CPA | Chief Officer | Profile |
Already Invested in Disc Medicine?
The danger of trading Disc Medicine is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Disc Medicine is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Disc Medicine. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Disc Medicine is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Disc Medicine offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Disc Medicine's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Disc Medicine Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Disc Medicine Stock: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Disc Medicine. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. To learn how to invest in Disc Stock, please use our How to Invest in Disc Medicine guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Complementary Tools for Disc Stock analysis
When running Disc Medicine's price analysis, check to measure Disc Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Disc Medicine is operating at the current time. Most of Disc Medicine's value examination focuses on studying past and present price action to predict the probability of Disc Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Disc Medicine's price. Additionally, you may evaluate how the addition of Disc Medicine to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Global Correlations Find global opportunities by holding instruments from different markets |
Is Disc Medicine's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Disc Medicine. If investors know Disc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Disc Medicine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.42) | Return On Assets (0.20) | Return On Equity (0.29) |
The market value of Disc Medicine is measured differently than its book value, which is the value of Disc that is recorded on the company's balance sheet. Investors also form their own opinion of Disc Medicine's value that differs from its market value or its book value, called intrinsic value, which is Disc Medicine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Disc Medicine's market value can be influenced by many factors that don't directly affect Disc Medicine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Disc Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Disc Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Disc Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.